Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Arteriosclerosis

Recruiting

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ro7790121

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Mirikizumab

Contact Research Centre

Crohn's disease

Recruiting

InvestigationalNo placebo

Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn's Disease

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Mirikizumab

Contact Research Centre

Dyslipidaemia

Recruiting

Investigational

Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Rbd5044 Sodium

Contact Research Centre

Graves' disease

Recruiting

Registered drug

Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Colitis ulcerative

Recruiting

InvestigationalNo placebo

Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Golimumab

Contact Research Centre

Chronic cutaneous lupus erythematosus+2

Recruiting

Investigational

Phase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Colitis ulcerative+2

Recruiting

InvestigationalNo placebo

Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Mirikizumab

Contact Research Centre

Obesity

Recruiting

Investigational

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Mirikizumab

Contact Research Centre

Metabolic dysfunction-associated liver disease

Recruiting

Investigational

N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ly3437943 Sodium

Contact Research Centre

Find therapies in clinical trials near you – page 2

92 trials match your criteria

Arteriosclerosis

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Crohn's disease

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Colitis ulcerative

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Crohn's disease

Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn's Disease

Dyslipidaemia

Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness

Graves' disease

Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

Colitis ulcerative

Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

Chronic cutaneous lupus erythematosus+2

Phase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)

Colitis ulcerative+2

Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

Obesity

RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Colitis ulcerative

A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

Metabolic dysfunction-associated liver disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.